<![CDATA[I've never fully understood why Insilico Medicine is so popular.]]>I've never fully understood why Insilico Medicine is so popular. But talking to CEO Alex Zhavoronkov, you start to understand why the company is the way it is — and why he wants to model it after SpaceX.

What makes a "productive" AI drug development company? Are the pros and cons of licensing vs partnerships different for AI biotechs? And what does Alex really think of Flagship?

https://www.statnews.com/2026/04/01/insilico-medicine-ceo-biotech-drug-development-ai-prognosis/

]]>https://postcall.pub/topic/7041ec46-87ac-4069-a975-d0691ac7751f/i-ve-never-fully-understood-why-insilico-medicine-is-so-popular.RSS for NodeFri, 03 Apr 2026 20:15:58 GMTWed, 01 Apr 2026 14:43:26 GMT60